27-04-2021 10:36 |
The
period of administration of the 2nd dose of the AstraZeneca vaccine is
reduced to eight weeks |
After reviewing and evaluating
the data arising from international studies on real vaccinations, as well as
the recommendation in the Instructions for Use Leaflet of the AstraZeneca
Vaccine, it was decided to reduce
the period between the 1st and the 2nd dose of this
vaccine from
12 to eight (8) weeks. The decision is implemented as of today,
and arrangements have already been made at the Vaccination Centres, so that
the appointments for the 2nd dose of the vaccine for those who
will be vaccinated from today onwards with AstraZeneca, can be scheduled on
the 8th week. Regarding those who have been
vaccinated with AstraZeneca before April 25, the following will apply:
The aim of the National
Vaccination Plan is to proceed rapidly with the vaccination of the majority
of the population with the available licensed vaccines, in order to achieve a
significant level of immunity and to protect
citizens from serious illness and hospitalization. According to the data so far,
in Cyprus, 84% of
individuals aged 80 and over have been vaccinated at least
with the 1st dose while
in the age group of 70-79, 80% of individuals have been
vaccinated. The data is reflected in the hospitalizations, since the
hospitalization number of individuals in this age group has decreased
significantly. During the current period, individuals aged 45 and over are
being vaccinated, and at the same time, during this week, people aged 39-44
are given priority for the arrangement of vaccination appointments. MPO |